Related Experiment Video

Updated: Jun 24, 2025

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

3.7K

Pyroptosis of Vascular Smooth Muscle Cells as a Potential New Target for Preventing Vascular Diseases

Chang Di1,2,3,4,5, Meng Ji6,7,8,9,10, Wenjin Li6,7,8,9,10

  • 1Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Beijing, 100191, Haidian District, China. dichang@pku.edu.cn.

Cardiovascular Drugs and Therapy
|June 1, 2024
PubMed

Insights

Inhibiting vascular smooth muscle cell (VSMC) pyroptosis can slow vascular remodeling. Targeting VSMC pyroptosis offers a new strategy for treating vascular diseases by controlling cell death and inflammation.

Area of Science:

  • Cardiovascular Biology
  • Cellular Pathology
  • Molecular Medicine

Background:

  • Vascular remodeling is a key factor in vascular diseases.
  • Vascular smooth muscle cells (VSMCs) are central to this process.
  • Pyroptosis, a pro-inflammatory cell death, drives VSMC changes and accelerates vascular remodeling.

Purpose of the Study:

  • To review the role of pyroptosis in VSMCs.
  • To examine the pathogenic contribution of VSMC pyroptosis to vascular remodeling.
  • To discuss therapeutic strategies targeting VSMC pyroptosis.

Main Methods:

  • Literature review of pyroptosis mechanisms in VSMCs.
  • Analysis of the link between VSMC pyroptosis and vascular remodeling.
  • Evaluation of inhibitors targeting pyroptosis pathways.

Main Results:

  • Pyroptosis induces VSMC phenotypic transformation, proliferation, migration, and calcification.
  • VSMC pyroptosis significantly contributes to the acceleration of vascular remodeling.
  • Inhibitors of pyroptosis pathways show potential in mitigating VSMC pyroptosis.

Conclusions:

  • VSMC pyroptosis is a critical driver of vascular remodeling.
  • Targeting VSMC pyroptosis presents a promising therapeutic avenue for vascular diseases.
  • Further research into pyroptosis inhibitors could lead to novel treatments.
Keywords:
PyroptosisVSMCVascular diseasesVascular remodeling

More Related Videos

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

8.3K
In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium10:18

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

Published on: May 6, 2018

9.3K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K